Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia
Fadlyana, Eddy, Setiabudi, Djatnika, Kartasasmita, C B, Putri, Nina Dwi, Rezeki Hadinegoro, Sri, Mulholland, Kim, Sofiatin, Yulia, Suryadinata, Hendarsyah, Hartantri, Yovita, Sukandar, Hadyana, Indrati, Agnes Rengga, Murad, Chrysanti, Setiawaty, Vivi, Pangesti, Krisna Nur Andriana, Multihartina, Pretty, Khrisna, Citra Vravita, Ayuninda, Masayu Riela, Wicaksana, Pratama, Zhafira, Aqila Sakina, Sinto, Robert, Rusmil, Kusnandi, Sundoro, Julitasari, Watts, Emma, Nguyen, Cattram
Published in The Lancet infectious diseases (01.05.2023)
Published in The Lancet infectious diseases (01.05.2023)
Get full text
Journal Article